Agios Pharmaceuticals, Inc. (AGIO)
Pre-Market:
- GlobeNewswire
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. ET. A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. A re
- Simply Wall St.
Agios Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Agios Pharmaceuticals ( NASDAQ:AGIO ) First Quarter 2024 Results Key Financial Results Revenue: US$8.19m (up 46% from...
- GuruFocus.com
Agios Pharmaceuticals Inc (AGIO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Agios Pharmaceuticals showcases a strong Q1 with significant progress in clinical trials and a solid cash reserve, setting the stage for future growth.
